Elevance Health reaffirms FY2023 adjusted EPS guidance >$32.70

Elevance Health, Inc.

Net income guidance >$29.50 per share including ~$3.20 net unfavorable items.
Adjusted net income guidance >$32.70 per share, excluding items from Q1 2023 earnings.
Company officers to meet with investors over upcoming weeks; reaffirms prior outlook.

item 7.01

Elevance Health, Inc. filing history →

Source: SEC EDGAR

accession 0001156039-23-000082

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.